{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidwen2asrjracfeg75htifguts2ubal4kxdpphnnguk4kegjbg3rm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhrocbvm4qp2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig6u6zdo3zr4k7lhmgg7aduamffitjrmku2ow6vehrd5bxurp7btu"
    },
    "mimeType": "image/jpeg",
    "size": 69174
  },
  "path": "/2026/03/23/insmed-mac-lung-infection-arikayce-results/?utm_campaign=rss",
  "publishedAt": "2026-03-23T11:00:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "STAT+"
  ],
  "textContent": "Insmed hopes to convert Arikayce's accelerated approval to a full approval.",
  "title": "STAT+: Insmed drug benefits patients with rare, bacterial lung disease, study shows",
  "updatedAt": "2026-03-23T16:28:39.000Z"
}